Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.79 - $1.02 $202 - $261
256 Added 125.49%
460 $0
Q1 2024

Nov 05, 2024

SELL
$0.96 - $1.25 $245 - $320
-256 Reduced 55.65%
204 $0
Q1 2024

May 15, 2024

SELL
$0.96 - $1.25 $284 - $370
-296 Reduced 59.2%
204 $0
Q4 2023

Feb 14, 2024

SELL
$1.03 - $1.99 $4,480 - $8,656
-4,350 Reduced 89.69%
500 $0
Q3 2023

Nov 14, 2023

BUY
$1.85 - $3.17 $8,835 - $15,139
4,776 Added 6454.05%
4,850 $9,000
Q2 2023

Aug 14, 2023

SELL
$1.25 - $2.32 $467 - $867
-374 Reduced 83.48%
74 $0
Q1 2023

May 15, 2023

BUY
$0.83 - $1.88 $371 - $842
448 New
448 $0
Q3 2022

Nov 14, 2022

BUY
$0.81 - $2.06 $287 - $731
355 New
355 $0
Q2 2022

Aug 15, 2022

SELL
$1.95 - $4.05 $195 - $405
-100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.01 - $10.92 $701 - $1,092
100 New
100 $1,000

Others Institutions Holding HYPR

About Hyperfine, Inc.


  • Ticker HYPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,515,500
  • Market Cap $47.7M
  • Description
  • Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
More about HYPR
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.